STOCK TITAN

Butterfly Network, Inc. - BFLY STOCK NEWS

Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.

Butterfly Network, Inc. (BFLY) is revolutionizing the healthcare landscape with its innovative digital health solutions, primarily focused on handheld, whole-body ultrasound technology. The company, which operates at the nexus of advanced engineering and scientific disciplines, has assembled a team of world-class talents in computer science, physics, and electrical engineering. Underpinned by a robust financial foundation from a select group of highly successful serial entrepreneurs, Butterfly Network is uniquely positioned to dedicate its full attention to product and intellectual property development.

Butterfly Network's flagship product, the Butterfly iQ+, represents a significant leap in medical imaging technology. This compact, user-friendly device leverages the company's proprietary Ultrasound-on-Chip technology to enable healthcare professionals to perform comprehensive whole-body imaging using a single handheld probe. The device's affordability and portability make it a game-changer in clinical settings, ensuring that high-quality ultrasound imaging is accessible and practical for a wide range of medical applications.

The integration of cloud-connected software with hardware technology further enhances the utility of the Butterfly iQ+, allowing for seamless data acquisition and analysis via a mobile application. This connectivity facilitates the practical application of ultrasound information within clinical workflows, thereby improving diagnostic capabilities and patient outcomes.

Recent achievements and ongoing projects include advancements in ultrasound technology and the expansion of the product's applications in various medical fields. The company's commitment to innovation is reflected in its continuous efforts to enhance the performance and capabilities of its devices.

With a strong focus on R&D and a strategic approach to technological development, Butterfly Network is poised to make significant contributions to digital health and medical imaging. The company's progress and updates can be closely followed through the latest news and press releases, which provide valuable insights into its performance, events, and developments.

Rhea-AI Summary

Butterfly Network has launched its first specialty product, iQ+ Bladder, aimed at the bladder scanning market in the United States.

This product expands Butterfly's reach beyond its core point-of-care ultrasound market, leveraging its proprietary Ultrasound-on-Chip™ technology. The bundled solution includes an iQ+ Bladder probe, streamlined software, a compact rolling cart, a tablet, and a power splitter.

The iQ+ Bladder enables nurses to obtain automated bladder volume calculations with 3D visualizations swiftly. The user-friendly interface, robust design, and advanced visualization capabilities make it a valuable tool in today's healthcare environment, targeting efficiency, reliability, and workflow optimization. The product is designed to meet the needs of nurses and other providers who conduct regular bladder scans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.8%
Tags
none
-
Rhea-AI Summary

Butterfly Network, Inc. (NYSE: BFLY) reported a 14% revenue growth in the first quarter of 2024, exceeding expectations. The company achieved record revenue of $17.7 million, reduced net loss by 35%, and net cash used in operations by 52%. They successfully launched the Butterfly iQ3™ and ScanLab™ training app, received EU MDR certification, and announced plans to expand into the European market. Butterfly Network's recent operational highlights include FDA clearance for the Butterfly iQ3™, EU MDR certification for the Butterfly iQ+, and the launch of ScanLab™. The company's gross profit was $10.3 million, with a gross margin of 58.2%. Operating expenses decreased by 25% to $32.9 million, resulting in a net loss of $21.8 million. Adjusted EBITDA loss was $13.2 million. Butterfly Network raised its full year guidance for 2024 to $75-80 million in revenue, with an adjusted EBITDA loss of $55-50 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.15%
Tags
-
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will report its first quarter 2024 financial results on May 1, 2024. The company, known for its handheld, whole-body ultrasound technology, will host a conference call and webcast to discuss the financial results and operational progress. Investors and stakeholders can access the live webcast and archived call on Butterfly's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9%
Tags
conferences earnings
Rhea-AI Summary
Butterfly Network, CHAI, and GUSI collaborate to enhance maternal and fetal health in South Africa through a $5M grant from the Gates Foundation. Phase Two of the program involves distributing 500 iQ+ ultrasound devices to healthcare workers in South Africa for obstetric screenings and training.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.4%
Tags
partnership
-
Rhea-AI Summary
Myomo, Inc. (NYSE American: MYO) appoints Heather Getz as a Class II director and chair of its audit committee, bringing extensive corporate experience to the board. Ms. Getz's background in finance, healthcare, and strategic planning will aid Myomo's growth as it accelerates its development in wearable medical robotics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
management
-
Rhea-AI Summary
Butterfly Network, Inc. attains EU MDR certification for Butterfly iQ+ ultrasound system, enabling the release of advanced features like Pulse Wave Doppler and Auto B-Line Counter to European customers. The company plans to launch these functionalities within the second quarter of 2024, paving the way for the upcoming Butterfly iQ3 device in Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.63%
Tags
none
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) aims for revenue exceeding $500 million by 2030 and to achieve cash flow breakeven by the end of 2027. The company introduced plans to expand into new markets, including HomeCare Services, with phased rollouts for bladder and lung care. Butterfly showcased its next-generation wearable devices and strategic partnerships in AI applications. The CEO emphasized the company's leadership in the digital ultrasound revolution and its readiness to serve all point-of-care ultrasound use cases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) to host Investor Day at NYSE, showcasing handheld ultrasound technology and software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
-
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) announced participation in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. Joseph DeVivo and Heather Getz will lead a fireside chat and one-on-one investor meetings, emphasizing their digital health innovations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
conferences
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) announces strong financial results for 2023, with $65.9 million in revenue, cost savings of over $170 million, and new product launches positioning the company for growth. The launch of the iQ3 ultrasound system and ScanLab app, along with upcoming initiatives, sets the stage for continued success in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.59%
Tags

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $3.11 as of December 24, 2024.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 662.6M.

What is Butterfly Network, Inc.?

Butterfly Network, Inc. is a digital health company focused on revolutionizing healthcare with its handheld, whole-body ultrasound technology.

What product does Butterfly Network offer?

The company's flagship product is the Butterfly iQ+, a handheld ultrasound device that utilizes proprietary Ultrasound-on-Chip technology for whole-body imaging.

How does the Butterfly iQ+ work?

The Butterfly iQ+ combines a handheld probe with cloud-connected software, allowing healthcare professionals to perform comprehensive whole-body imaging using a mobile application.

What makes Butterfly Network's technology unique?

Butterfly Network's technology is unique due to its Ultrasound-on-Chip technology, which enables high-quality imaging in a compact, affordable device that's easy to use.

Who funds Butterfly Network?

Butterfly Network is privately funded by a small group of extraordinarily successful serial entrepreneurs.

What are the recent achievements of Butterfly Network?

Recent achievements include advancements in ultrasound technology and the expansion of applications for their handheld devices across various medical fields.

How does Butterfly Network contribute to healthcare?

Butterfly Network contributes to healthcare by making high-quality ultrasound imaging accessible and practical, thus improving diagnostic capabilities and patient outcomes.

Is Butterfly Network publicly traded?

Yes, Butterfly Network, Inc. is publicly traded under the symbol BFLY.

Can the Butterfly iQ+ be used in multiple medical settings?

Yes, the Butterfly iQ+ is designed for use in a wide range of medical settings, providing versatile imaging capabilities.

Where can I find the latest news on Butterfly Network?

The latest news and updates on Butterfly Network can be found through their official press releases and stock market updates.

Butterfly Network, Inc.

NYSE:BFLY

BFLY Rankings

BFLY Stock Data

662.62M
155.82M
16.79%
27.56%
5.96%
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
BURLINGTON